SlideShare a Scribd company logo
1 of 29
Strategic Approach to an Integrated KOL Program   Andrew Scheifele, Ph.D. Executive Director, Regional Medical Liaisons Scientific Affairs, Amgen The content and opinions expressed in this presentation are solely those of the presenter and do not necessarily reflect those of Amgen.  The presenter does not speak on behalf of Amgen.
Strategic Approach to an Integrated KOL Program ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Hidden Slide
What is an Opinion Leader and Why Do We Need Them? ,[object Object],[object Object],1 Rogers, Everett M. (2003). “Diffusion of Innovations,” 5 th  Ed., The Free Press, New York. 2 Coleman, James S., Elihu Katz, and Herbert Menzel. (1966), “Medical Innovation:  A Diffusion Study,” The Bobbs-Merrill Company, Indianapolis, IN
Some Characteristics of Key Opinion Leaders ,[object Object],[object Object],[object Object],[object Object],Nair, H., Manchanda, P., and Bhatia, T.,  “Asymmetric Peer Effects in Physician Prescription Behavior: The Role of the Opinion Leaders.”  Research Paper Series, Stanford Graduate School of Business, December 2006.
Key Opinion Leaders Impact Physician Peers Predominantly Through Direct Contact ,[object Object],[object Object],[object Object],[object Object],[object Object],Nair, H., Manchanda, P., and Bhatia, T.,  “Asymmetric Peer Effects in Physician Prescription Behavior: The Role of the Opinion Leaders.”  Research Paper Series, Stanford Graduate School of Business, December 2006.
[object Object],[object Object],[object Object],Strategic  Needs Collaboration MSL’s Role
[object Object],[object Object],Strategic Needs Collaboration MSL’s Role
The Potential for Mutually Beneficial Collaborations ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Option A: Bottom Up “Tactical” Approach – The Easy Solution Study A Investigator 1 Investigator 2 Investigator 3 Investigator 4 Investigator … Study B Investigator 1 Investigator 2 Investigator 3 Investigator 4 Investigator … Ad Board Advisor 1 Advisor 2 Advisor 3 Advisor … Publication Author 1 Author 2 Author 3 Speakers Bureau Speaker 1 Speaker 2 Speaker 3 Speaker …
A Silo-ed, Bottom Up Approach Results in Unbalanced KOL Engagement 3 trials 6 publications 4 ad boards Major Speaker 2 trials No engagement Thought Leader 1 Thought Leader 2 Thought Leader 3
Option B: Top Down “Strategic” Approach – More Complex Study Thought Leader 1 Study Ad Board Publication Speakers Bureau Study Study Thought Leader 2 Thought Leader 3 Thought Leader 4 Thought Leader 5 Thought Leader 6 Ad Board Publication Publication Ad Board Photo:  http://www.lakemartinvoice.com/wp-content/uploads/holding_20map.jpg
Requirements ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],Collaboration Strategic Approach MSL’s Role
Why an integrated approach? ,[object Object],Economist Intelligence Unit – Business 2010
identify your  barriers   to giving  a great experience http://andyhanselman.com
Company’s Perception Clearly delineated contacts for different roles CRA Sales Rep MSL Thought  Leader
Thought Leader’s Awareness Thought Leader Company: Medical Development Sales Marketing Multiple contacts within same company Some understanding of difference in roles
Thought Leader’s Perception Development Lead Clinical  Scientists Legal/ Contracting Sales  Rep (s) Med Comm Brand  Director (s) Medical  Director (s) Medical/  Reimbursement Call Center (s) CRA CRO (s) Vendors Medical Writing MSL Thought  Leader
Thought Leader’s Reality Thought Leader Company: Medical Development Sales Marketing Company: Medical Development Sales Marketing Company: Medical Development Sales Marketing Company: Medical Development Sales Marketing Company: Medical Development Sales Marketing Company: Medical Development Sales Marketing
The Problem Opinion Leader Time Span Product Life Cycle Team Member Turnover Products Functions Companies
A Team Approach to Thought Leader Engagement http://www.istockphoto.com  File Number: 4034846
Create an integrated KOL engagement plan  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Leverage Technology
Beyond CRM: KOL Databases ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
MSL’s Role Strategic Needs Collaboration ,[object Object]
MSLs as Primary Point of Contact ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
A Better Experience… Thought Leader Leveraging MSLs  as the primary point  of coordination &  contact for KOL  engagement Assessing your companies strategic needs for KOLs throughout the product lifecycle Building a coordinated approach for KOL engagement across functional departments Photo: http://www.flickr.com
Make the solution easy
Thank you! _______________________________________________________________ Andrew Scheifele, Ph.D.                                                              Executive Director | Regional Medical Liaisons | Bone Therapeutic Area Scientific Affairs  |  Amgen                                         ascheife@amgen.com   |  Office 805.447.9659 | Fax 805.480.1254

More Related Content

What's hot

Optimizing KOL Relationships Report Summary
Optimizing KOL Relationships Report SummaryOptimizing KOL Relationships Report Summary
Optimizing KOL Relationships Report SummaryBest Practices
 
Medical Science Liaison-Aligning The Activities And Goals Of Medical Science ...
Medical Science Liaison-Aligning The Activities And Goals Of Medical Science ...Medical Science Liaison-Aligning The Activities And Goals Of Medical Science ...
Medical Science Liaison-Aligning The Activities And Goals Of Medical Science ...Medical Science Liaison Society
 
Medical Science Liaison (MSL) and KOL Regulatory Compliance
Medical Science Liaison (MSL) and KOL Regulatory ComplianceMedical Science Liaison (MSL) and KOL Regulatory Compliance
Medical Science Liaison (MSL) and KOL Regulatory ComplianceMedical Science Liaison Society
 
10 essential questions for successful kol management
10 essential questions for successful kol management10 essential questions for successful kol management
10 essential questions for successful kol managementexecutiveinsight
 
New Product Planning in the Pharmaceutical Industry
New Product Planning in the Pharmaceutical IndustryNew Product Planning in the Pharmaceutical Industry
New Product Planning in the Pharmaceutical IndustryAnthony Russell
 
Pharmacovigilance
Pharmacovigilance Pharmacovigilance
Pharmacovigilance kiran pala
 
CRM un pharmaceutical industry
CRM un pharmaceutical industryCRM un pharmaceutical industry
CRM un pharmaceutical industrygauravamity
 
Roles, Resources, and Managemet of Medical Science Liaisons
Roles, Resources, and Managemet of Medical Science LiaisonsRoles, Resources, and Managemet of Medical Science Liaisons
Roles, Resources, and Managemet of Medical Science LiaisonsBest Practices, LLC
 
Best in-class Medical Science Liasons
Best in-class Medical Science LiasonsBest in-class Medical Science Liasons
Best in-class Medical Science LiasonsJean-Michel Peny
 
Business Strategy For Small Pharma Companies
Business Strategy For Small Pharma CompaniesBusiness Strategy For Small Pharma Companies
Business Strategy For Small Pharma Companiesdebalinachoudhury
 
Top 10 pharmacovigilance officer interview questions and answers
Top 10 pharmacovigilance officer interview questions and answersTop 10 pharmacovigilance officer interview questions and answers
Top 10 pharmacovigilance officer interview questions and answerstonychoper3006
 
Artificial intelligence in Pharmacovigilance
Artificial intelligence in PharmacovigilanceArtificial intelligence in Pharmacovigilance
Artificial intelligence in PharmacovigilanceSMS MEDICAL COLLEGE
 
How to write Pharma marketing plan ?
How to write Pharma marketing plan ?How to write Pharma marketing plan ?
How to write Pharma marketing plan ?Modjtaba Babazadeh
 

What's hot (20)

Optimizing KOL Relationships Report Summary
Optimizing KOL Relationships Report SummaryOptimizing KOL Relationships Report Summary
Optimizing KOL Relationships Report Summary
 
Medical Science Liaison-Aligning The Activities And Goals Of Medical Science ...
Medical Science Liaison-Aligning The Activities And Goals Of Medical Science ...Medical Science Liaison-Aligning The Activities And Goals Of Medical Science ...
Medical Science Liaison-Aligning The Activities And Goals Of Medical Science ...
 
Case study ABC Pharmaceutical Company
Case study ABC Pharmaceutical CompanyCase study ABC Pharmaceutical Company
Case study ABC Pharmaceutical Company
 
Medical Science Liaison (MSL) and KOL Regulatory Compliance
Medical Science Liaison (MSL) and KOL Regulatory ComplianceMedical Science Liaison (MSL) and KOL Regulatory Compliance
Medical Science Liaison (MSL) and KOL Regulatory Compliance
 
10 essential questions for successful kol management
10 essential questions for successful kol management10 essential questions for successful kol management
10 essential questions for successful kol management
 
New Product Planning in the Pharmaceutical Industry
New Product Planning in the Pharmaceutical IndustryNew Product Planning in the Pharmaceutical Industry
New Product Planning in the Pharmaceutical Industry
 
Pharmacovigilance
Pharmacovigilance Pharmacovigilance
Pharmacovigilance
 
Case study examples from industry
Case study examples from industryCase study examples from industry
Case study examples from industry
 
CRM un pharmaceutical industry
CRM un pharmaceutical industryCRM un pharmaceutical industry
CRM un pharmaceutical industry
 
Gaps in Medical Science Liaison Training
Gaps in Medical Science Liaison TrainingGaps in Medical Science Liaison Training
Gaps in Medical Science Liaison Training
 
Pharma business models
Pharma business modelsPharma business models
Pharma business models
 
Roles, Resources, and Managemet of Medical Science Liaisons
Roles, Resources, and Managemet of Medical Science LiaisonsRoles, Resources, and Managemet of Medical Science Liaisons
Roles, Resources, and Managemet of Medical Science Liaisons
 
Best in-class Medical Science Liasons
Best in-class Medical Science LiasonsBest in-class Medical Science Liasons
Best in-class Medical Science Liasons
 
Business Strategy For Small Pharma Companies
Business Strategy For Small Pharma CompaniesBusiness Strategy For Small Pharma Companies
Business Strategy For Small Pharma Companies
 
What is a Medical Science Liaison?
What is a Medical Science Liaison?What is a Medical Science Liaison?
What is a Medical Science Liaison?
 
Top 10 pharmacovigilance officer interview questions and answers
Top 10 pharmacovigilance officer interview questions and answersTop 10 pharmacovigilance officer interview questions and answers
Top 10 pharmacovigilance officer interview questions and answers
 
Artificial intelligence in Pharmacovigilance
Artificial intelligence in PharmacovigilanceArtificial intelligence in Pharmacovigilance
Artificial intelligence in Pharmacovigilance
 
Opportunities in Clinical Research
Opportunities in Clinical ResearchOpportunities in Clinical Research
Opportunities in Clinical Research
 
How to write Pharma marketing plan ?
How to write Pharma marketing plan ?How to write Pharma marketing plan ?
How to write Pharma marketing plan ?
 
Pharmacovigilance System
Pharmacovigilance SystemPharmacovigilance System
Pharmacovigilance System
 

Viewers also liked

iHT² Health IT Summit Beverly Hills – Case Study "The EHR & Quality: The Curr...
iHT² Health IT Summit Beverly Hills – Case Study "The EHR & Quality: The Curr...iHT² Health IT Summit Beverly Hills – Case Study "The EHR & Quality: The Curr...
iHT² Health IT Summit Beverly Hills – Case Study "The EHR & Quality: The Curr...Health IT Conference – iHT2
 
Mc kinsey- building new strenghts in healthcare supply chain
Mc kinsey- building new strenghts in healthcare supply chainMc kinsey- building new strenghts in healthcare supply chain
Mc kinsey- building new strenghts in healthcare supply chainUtkan Uluçay, MSc., CDDP
 
New_DPAc_external_presentation_Mar15
New_DPAc_external_presentation_Mar15New_DPAc_external_presentation_Mar15
New_DPAc_external_presentation_Mar15Andrew Pope
 
2016/01 - JP Morgan HC Conference
2016/01 - JP Morgan HC Conference2016/01 - JP Morgan HC Conference
2016/01 - JP Morgan HC ConferenceSanofi
 
Minnesota Method - University Industry Partnerships
Minnesota Method - University Industry Partnerships Minnesota Method - University Industry Partnerships
Minnesota Method - University Industry Partnerships Leza Besemann
 
5 powerful ideas on KOL network management
5 powerful ideas on KOL network management5 powerful ideas on KOL network management
5 powerful ideas on KOL network managementexecutiveinsight
 
"Fostering Massachusetts' life science ecosystem", Dr. Susan Windham-Banniste...
"Fostering Massachusetts' life science ecosystem", Dr. Susan Windham-Banniste..."Fostering Massachusetts' life science ecosystem", Dr. Susan Windham-Banniste...
"Fostering Massachusetts' life science ecosystem", Dr. Susan Windham-Banniste...MIT Startup Exchange
 
Key Opinion Leader Compensation and KOL and Medical Science Liaison Interactions
Key Opinion Leader Compensation and KOL and Medical Science Liaison InteractionsKey Opinion Leader Compensation and KOL and Medical Science Liaison Interactions
Key Opinion Leader Compensation and KOL and Medical Science Liaison InteractionsMedical Science Liaison Society
 
Better Biotech Innovation by Improving the Ecosystem by Tim Charlebois, VP In...
Better Biotech Innovation by Improving the Ecosystem by Tim Charlebois, VP In...Better Biotech Innovation by Improving the Ecosystem by Tim Charlebois, VP In...
Better Biotech Innovation by Improving the Ecosystem by Tim Charlebois, VP In...MIT Startup Exchange
 
Medical affairs department for small organization
Medical affairs department for small organizationMedical affairs department for small organization
Medical affairs department for small organizationDr. Zubair Ali
 
Medical Affairs
Medical AffairsMedical Affairs
Medical Affairsmbielick
 
Annual Results 2016
Annual Results 2016Annual Results 2016
Annual Results 2016Sanofi
 
Highlights From 7th Medical Science Liaison/MSL Conference
Highlights From 7th Medical Science Liaison/MSL ConferenceHighlights From 7th Medical Science Liaison/MSL Conference
Highlights From 7th Medical Science Liaison/MSL ConferenceExL Pharma
 
Stakeholder Engagement: Simple Steps to Better Public Consultation
Stakeholder Engagement: Simple Steps to Better Public ConsultationStakeholder Engagement: Simple Steps to Better Public Consultation
Stakeholder Engagement: Simple Steps to Better Public ConsultationCam McAlpine, APR
 

Viewers also liked (17)

iHT² Health IT Summit Beverly Hills – Case Study "The EHR & Quality: The Curr...
iHT² Health IT Summit Beverly Hills – Case Study "The EHR & Quality: The Curr...iHT² Health IT Summit Beverly Hills – Case Study "The EHR & Quality: The Curr...
iHT² Health IT Summit Beverly Hills – Case Study "The EHR & Quality: The Curr...
 
Engaging with KOL online
Engaging with KOL onlineEngaging with KOL online
Engaging with KOL online
 
mHealth Manchester ecosystem
mHealth Manchester ecosystemmHealth Manchester ecosystem
mHealth Manchester ecosystem
 
Mc kinsey- building new strenghts in healthcare supply chain
Mc kinsey- building new strenghts in healthcare supply chainMc kinsey- building new strenghts in healthcare supply chain
Mc kinsey- building new strenghts in healthcare supply chain
 
New_DPAc_external_presentation_Mar15
New_DPAc_external_presentation_Mar15New_DPAc_external_presentation_Mar15
New_DPAc_external_presentation_Mar15
 
2016/01 - JP Morgan HC Conference
2016/01 - JP Morgan HC Conference2016/01 - JP Morgan HC Conference
2016/01 - JP Morgan HC Conference
 
Minnesota Method - University Industry Partnerships
Minnesota Method - University Industry Partnerships Minnesota Method - University Industry Partnerships
Minnesota Method - University Industry Partnerships
 
5 powerful ideas on KOL network management
5 powerful ideas on KOL network management5 powerful ideas on KOL network management
5 powerful ideas on KOL network management
 
The Digital KOL 6.2015
The Digital KOL 6.2015The Digital KOL 6.2015
The Digital KOL 6.2015
 
"Fostering Massachusetts' life science ecosystem", Dr. Susan Windham-Banniste...
"Fostering Massachusetts' life science ecosystem", Dr. Susan Windham-Banniste..."Fostering Massachusetts' life science ecosystem", Dr. Susan Windham-Banniste...
"Fostering Massachusetts' life science ecosystem", Dr. Susan Windham-Banniste...
 
Key Opinion Leader Compensation and KOL and Medical Science Liaison Interactions
Key Opinion Leader Compensation and KOL and Medical Science Liaison InteractionsKey Opinion Leader Compensation and KOL and Medical Science Liaison Interactions
Key Opinion Leader Compensation and KOL and Medical Science Liaison Interactions
 
Better Biotech Innovation by Improving the Ecosystem by Tim Charlebois, VP In...
Better Biotech Innovation by Improving the Ecosystem by Tim Charlebois, VP In...Better Biotech Innovation by Improving the Ecosystem by Tim Charlebois, VP In...
Better Biotech Innovation by Improving the Ecosystem by Tim Charlebois, VP In...
 
Medical affairs department for small organization
Medical affairs department for small organizationMedical affairs department for small organization
Medical affairs department for small organization
 
Medical Affairs
Medical AffairsMedical Affairs
Medical Affairs
 
Annual Results 2016
Annual Results 2016Annual Results 2016
Annual Results 2016
 
Highlights From 7th Medical Science Liaison/MSL Conference
Highlights From 7th Medical Science Liaison/MSL ConferenceHighlights From 7th Medical Science Liaison/MSL Conference
Highlights From 7th Medical Science Liaison/MSL Conference
 
Stakeholder Engagement: Simple Steps to Better Public Consultation
Stakeholder Engagement: Simple Steps to Better Public ConsultationStakeholder Engagement: Simple Steps to Better Public Consultation
Stakeholder Engagement: Simple Steps to Better Public Consultation
 

Similar to Scheifele Sept09final

Medical Science Liaison Webinarv 2009
Medical Science Liaison  Webinarv  2009Medical Science Liaison  Webinarv  2009
Medical Science Liaison Webinarv 2009Cameron Tew
 
Q n 1 strategic mgt
Q n 1 strategic mgtQ n 1 strategic mgt
Q n 1 strategic mgtkrehan85
 
Co p lance favourite model_170414
Co p lance favourite model_170414Co p lance favourite model_170414
Co p lance favourite model_170414Lance Whitworth
 
Hr value proposition
Hr value propositionHr value proposition
Hr value propositionsupreet28
 
Managing Corporate Reputation Cim Part 1
Managing Corporate Reputation Cim Part 1Managing Corporate Reputation Cim Part 1
Managing Corporate Reputation Cim Part 1David Phillips
 
E:\Managing Corporate Reputation Cim Part 1
E:\Managing Corporate Reputation Cim Part 1E:\Managing Corporate Reputation Cim Part 1
E:\Managing Corporate Reputation Cim Part 1David Phillips
 
Is Using Survey Research Valuable in Assessing Science Liaisons? PART 2
Is Using Survey Research Valuable in Assessing Science Liaisons? PART 2Is Using Survey Research Valuable in Assessing Science Liaisons? PART 2
Is Using Survey Research Valuable in Assessing Science Liaisons? PART 2Clinical SCORE
 
Organizational diagnosis
Organizational diagnosisOrganizational diagnosis
Organizational diagnosishidayahperlis
 
Strategic Management
Strategic ManagementStrategic Management
Strategic Managementssuserdcaa74
 
Measuring and Allocating MarCom Budgets
Measuring and Allocating MarCom BudgetsMeasuring and Allocating MarCom Budgets
Measuring and Allocating MarCom BudgetsEvgeny Tsarkov
 
Analyzing a company’s external environment
Analyzing a company’s external environmentAnalyzing a company’s external environment
Analyzing a company’s external environmentM.S. SaHiR
 
Wcm Cm Lecture 5 2004
Wcm   Cm   Lecture 5   2004Wcm   Cm   Lecture 5   2004
Wcm Cm Lecture 5 2004richard kemp
 
Week 1 Welcome to Business IT/Systems
Week 1 Welcome to Business IT/SystemsWeek 1 Welcome to Business IT/Systems
Week 1 Welcome to Business IT/SystemsJLuker
 
Assignment 2 LASA 1 Assignment—The Leader as a Strategist ReportF.docx
Assignment 2 LASA 1 Assignment—The Leader as a Strategist ReportF.docxAssignment 2 LASA 1 Assignment—The Leader as a Strategist ReportF.docx
Assignment 2 LASA 1 Assignment—The Leader as a Strategist ReportF.docxsteviesellars
 
12 March 2015 Employee Benefit Plan Review■ Focus On … Pla.docx
12 March 2015 Employee Benefit Plan Review■ Focus On … Pla.docx12 March 2015 Employee Benefit Plan Review■ Focus On … Pla.docx
12 March 2015 Employee Benefit Plan Review■ Focus On … Pla.docxdrennanmicah
 
Design Thinking: 5 Steps to Healthy Healthcare Apps
Design Thinking: 5 Steps to Healthy Healthcare AppsDesign Thinking: 5 Steps to Healthy Healthcare Apps
Design Thinking: 5 Steps to Healthy Healthcare AppsJeffery Belden
 

Similar to Scheifele Sept09final (20)

Medical Science Liaison Webinarv 2009
Medical Science Liaison  Webinarv  2009Medical Science Liaison  Webinarv  2009
Medical Science Liaison Webinarv 2009
 
Q n 1 strategic mgt
Q n 1 strategic mgtQ n 1 strategic mgt
Q n 1 strategic mgt
 
Co p lance favourite model_170414
Co p lance favourite model_170414Co p lance favourite model_170414
Co p lance favourite model_170414
 
Trendsppt
TrendspptTrendsppt
Trendsppt
 
Evidence-Based Practice in Health Care Management
Evidence-Based Practice in Health Care ManagementEvidence-Based Practice in Health Care Management
Evidence-Based Practice in Health Care Management
 
Hr value proposition
Hr value propositionHr value proposition
Hr value proposition
 
The Management Consultancy Industry
The Management Consultancy IndustryThe Management Consultancy Industry
The Management Consultancy Industry
 
Managing Corporate Reputation Cim Part 1
Managing Corporate Reputation Cim Part 1Managing Corporate Reputation Cim Part 1
Managing Corporate Reputation Cim Part 1
 
E:\Managing Corporate Reputation Cim Part 1
E:\Managing Corporate Reputation Cim Part 1E:\Managing Corporate Reputation Cim Part 1
E:\Managing Corporate Reputation Cim Part 1
 
Is Using Survey Research Valuable in Assessing Science Liaisons? PART 2
Is Using Survey Research Valuable in Assessing Science Liaisons? PART 2Is Using Survey Research Valuable in Assessing Science Liaisons? PART 2
Is Using Survey Research Valuable in Assessing Science Liaisons? PART 2
 
Session 1
Session 1Session 1
Session 1
 
Organizational diagnosis
Organizational diagnosisOrganizational diagnosis
Organizational diagnosis
 
Strategic Management
Strategic ManagementStrategic Management
Strategic Management
 
Measuring and Allocating MarCom Budgets
Measuring and Allocating MarCom BudgetsMeasuring and Allocating MarCom Budgets
Measuring and Allocating MarCom Budgets
 
Analyzing a company’s external environment
Analyzing a company’s external environmentAnalyzing a company’s external environment
Analyzing a company’s external environment
 
Wcm Cm Lecture 5 2004
Wcm   Cm   Lecture 5   2004Wcm   Cm   Lecture 5   2004
Wcm Cm Lecture 5 2004
 
Week 1 Welcome to Business IT/Systems
Week 1 Welcome to Business IT/SystemsWeek 1 Welcome to Business IT/Systems
Week 1 Welcome to Business IT/Systems
 
Assignment 2 LASA 1 Assignment—The Leader as a Strategist ReportF.docx
Assignment 2 LASA 1 Assignment—The Leader as a Strategist ReportF.docxAssignment 2 LASA 1 Assignment—The Leader as a Strategist ReportF.docx
Assignment 2 LASA 1 Assignment—The Leader as a Strategist ReportF.docx
 
12 March 2015 Employee Benefit Plan Review■ Focus On … Pla.docx
12 March 2015 Employee Benefit Plan Review■ Focus On … Pla.docx12 March 2015 Employee Benefit Plan Review■ Focus On … Pla.docx
12 March 2015 Employee Benefit Plan Review■ Focus On … Pla.docx
 
Design Thinking: 5 Steps to Healthy Healthcare Apps
Design Thinking: 5 Steps to Healthy Healthcare AppsDesign Thinking: 5 Steps to Healthy Healthcare Apps
Design Thinking: 5 Steps to Healthy Healthcare Apps
 

Scheifele Sept09final

  • 1. Strategic Approach to an Integrated KOL Program Andrew Scheifele, Ph.D. Executive Director, Regional Medical Liaisons Scientific Affairs, Amgen The content and opinions expressed in this presentation are solely those of the presenter and do not necessarily reflect those of Amgen. The presenter does not speak on behalf of Amgen.
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9. Option A: Bottom Up “Tactical” Approach – The Easy Solution Study A Investigator 1 Investigator 2 Investigator 3 Investigator 4 Investigator … Study B Investigator 1 Investigator 2 Investigator 3 Investigator 4 Investigator … Ad Board Advisor 1 Advisor 2 Advisor 3 Advisor … Publication Author 1 Author 2 Author 3 Speakers Bureau Speaker 1 Speaker 2 Speaker 3 Speaker …
  • 10. A Silo-ed, Bottom Up Approach Results in Unbalanced KOL Engagement 3 trials 6 publications 4 ad boards Major Speaker 2 trials No engagement Thought Leader 1 Thought Leader 2 Thought Leader 3
  • 11. Option B: Top Down “Strategic” Approach – More Complex Study Thought Leader 1 Study Ad Board Publication Speakers Bureau Study Study Thought Leader 2 Thought Leader 3 Thought Leader 4 Thought Leader 5 Thought Leader 6 Ad Board Publication Publication Ad Board Photo: http://www.lakemartinvoice.com/wp-content/uploads/holding_20map.jpg
  • 12.
  • 13.
  • 14.
  • 15. identify your barriers to giving a great experience http://andyhanselman.com
  • 16. Company’s Perception Clearly delineated contacts for different roles CRA Sales Rep MSL Thought Leader
  • 17. Thought Leader’s Awareness Thought Leader Company: Medical Development Sales Marketing Multiple contacts within same company Some understanding of difference in roles
  • 18. Thought Leader’s Perception Development Lead Clinical Scientists Legal/ Contracting Sales Rep (s) Med Comm Brand Director (s) Medical Director (s) Medical/ Reimbursement Call Center (s) CRA CRO (s) Vendors Medical Writing MSL Thought Leader
  • 19. Thought Leader’s Reality Thought Leader Company: Medical Development Sales Marketing Company: Medical Development Sales Marketing Company: Medical Development Sales Marketing Company: Medical Development Sales Marketing Company: Medical Development Sales Marketing Company: Medical Development Sales Marketing
  • 20. The Problem Opinion Leader Time Span Product Life Cycle Team Member Turnover Products Functions Companies
  • 21. A Team Approach to Thought Leader Engagement http://www.istockphoto.com File Number: 4034846
  • 22.
  • 24.
  • 25.
  • 26.
  • 27. A Better Experience… Thought Leader Leveraging MSLs as the primary point of coordination & contact for KOL engagement Assessing your companies strategic needs for KOLs throughout the product lifecycle Building a coordinated approach for KOL engagement across functional departments Photo: http://www.flickr.com
  • 29. Thank you! _______________________________________________________________ Andrew Scheifele, Ph.D.                                                              Executive Director | Regional Medical Liaisons | Bone Therapeutic Area Scientific Affairs | Amgen                                         ascheife@amgen.com   |  Office 805.447.9659 | Fax 805.480.1254

Editor's Notes

  1. 08.01.10 Executive Directors and Officers Meeting
  2. 08.01.10 Executive Directors and Officers Meeting
  3. A poor experience
  4. A great experience